educating and advancing platform vaccine development
2025 · 2nd Quarter (Apr 1 - June 30)
VOLTRON THERAPEUTICS
Filed by G2G CONSULTING.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 13, 2025
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- G2G CONSULTING
- Client
- VOLTRON THERAPEUTICS
- Filing UUID
- 73ad2d5d-099c-4b52-9c3c-e11c5b72b4e8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.